ProCE Banner Activity

Medical Minute 1—Early Stability: LAI Antipsychotics in Preventing Relapse

Slideset

Download part 1 of this 6-part slideset, where we discuss the current state of LAI AP underuse and reasons behind this gap in care.  Clinical evidence supports the use of LAI AP use in patients' first episodes or early in in their treatment course to prevent relapse and hospitalization.

Released: August 23, 2024

Expiration: August 22, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Indivior Inc.; Otsuka America Pharmaceutical, Inc. and Lundbeck; and Teva Pharmaceuticals.

Indivior Inc.

Otsuka America Pharmaceutical, Inc. and Lundbeck

Teva Pharmaceuticals